Latest News

STAT Plus: Teladoc rival MDLive is preparing to go public next year



On the heels of Teladoc’s landscape-shifting deal to buy Livongo, telemedicine rival MDLive is setting its sights on a public offering early next year, the company’s chief executive officer told STAT.

The deal, which is still in the early stages, would take place some time in January or February of next year, according to CEO Charles Jones. Jones added that Teladoc’s $18.5 billion planned acquisition of Livongo, announced earlier this month, bolstered his decision to push the company toward a market debut. Teladoc became the first telemedicine company to IPO in 2015, and remains the only major telehealth provider that is publicly traded.

Continue to STAT Plus to read the full story…

Source link

Related posts

How drug resistant TB evolved and spread globally

Newsemia

Faith, hope and apathy. Politics and Popular Opinion in Thuringia, 1945-1968

Newsemia

The Truth About Saturated Fat Being Bad For The Heart

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World